Who we are
About us
Our values
Environmental, social & governance
Therapeutic areas
What we do
Consulting (Acsel Health)
HEOR & market access
Scientific communications
Creative communications
Patient engagement
Insights
News & Events
Join us
Careers
Reasons to join
Contact us
Menu
Menu
Home /
Insights
Insights
Read our latest news and insights to keep on top of the trends and changes around the world.
All
Articles
Whitepapers
Case studies
Webinars
Podcasts
Filter by service
All
Consulting (Acsel Health)
Commercial excellence
Commercial strategy
Pricing & market access
Medical & scientific strategy
HEOR & market access
Market access strategy
Health economic modeling & meta-analysis
Real-world evidence & data analytics
Patient-centered outcomes
Scientific communications
Medical communications
Medical Affairs strategy
Publications planning & delivery
MSL strategy & content
Creative communications
Patient engagement
Strategy, insights & market research
Patient Engager™ program and advocacy engagement
Health psychology & behavior science
Patient content & storytelling
Articles
What is adult learning theory and how can it be used to help maximise your team’s potential?
Articles
•
Scientific communications
The role of medical affairs in positive and appropriate engagement with patient advocacy groups
Articles
•
Multiple Services
OPEN Health’s response to the FDA’s guidance on long term follow up post gene therapy
Articles
•
Multiple Services
Empowering and equipping medical affairs teams to embrace an ever-expanding remit
Articles
•
Scientific communications, Medical Affairs strategy
Improving healthcare communications in rare disease and orphan drugs
Articles
•
Multiple Services
Why patient engagement really matters
Articles
•
Multiple Services
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Articles
•
Multiple Services
Spotlight interview: 15 minutes on digital in medical communications
Articles
•
Multiple Services
Generating data on long-term outcomes with gene and other advanced therapies
Articles
•
HEOR & market access, Market access strategy, Patient-centered outcomes
Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?
Articles
•
HEOR & market access, Patient-centered outcomes
OPEN Health reflections on the World Orphan Drug Congress in Barcelona
Articles
•
Multiple Services
Patient journey mapping: exploring the clinical and the emotional journey
Articles
•
Multiple Services
<
1
2
…
12
13
14
15
16
>
Scroll to top